Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cvrx Inc (CVRX)

Cvrx Inc (CVRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 328,049
  • Shares Outstanding, K 24,264
  • Annual Sales, $ 39,300 K
  • Annual Income, $ -41,200 K
  • EBIT $ -59 M
  • EBITDA $ -58 M
  • 60-Month Beta 1.16
  • Price/Sales 8.29
  • Price/Cash Flow N/A
  • Price/Book 5.00

Options Overview Details

View History
  • Implied Volatility 90.74% ( +21.64%)
  • Historical Volatility 107.42%
  • IV Percentile 73%
  • IV Rank 42.59%
  • IV High 190.08% on 05/28/24
  • IV Low 17.05% on 06/07/24
  • Put/Call Vol Ratio 1.67
  • Today's Volume 8
  • Volume Avg (30-Day) 142
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 2,399
  • Open Int (30-Day) 7,958

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.38
  • Number of Estimates 3
  • High Estimate -0.37
  • Low Estimate -0.39
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +13.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.82 +50.41%
on 10/23/24
15.95 -7.40%
on 11/08/24
+4.51 (+43.96%)
since 10/21/24
3-Month
6.79 +117.53%
on 10/10/24
15.95 -7.40%
on 11/08/24
+6.43 (+77.10%)
since 08/21/24
52-Week
6.40 +130.78%
on 06/04/24
33.13 -55.42%
on 12/29/23
-4.42 (-23.03%)
since 11/21/23

Most Recent Stories

More News
CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference

CVRX : 14.77 (+9.25%)
CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025

CVRX : 14.77 (+9.25%)
CVRx: Q3 Earnings Snapshot

CVRx: Q3 Earnings Snapshot

CVRX : 14.77 (+9.25%)
CVRx Reports Third Quarter 2024 Financial and Operating Results

CVRX : 14.77 (+9.25%)
CVRx announces new CPT® Category I codes for Barostim

CVRX : 14.77 (+9.25%)
CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

CVRX : 14.77 (+9.25%)
CVRx: Q2 Earnings Snapshot

CVRx: Q2 Earnings Snapshot

CVRX : 14.77 (+9.25%)
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On

Unsurprisingly, Johnson & Johnson's top investments are all in the healthcare sector.

NVS : 103.85 (+0.74%)
JNJ : 155.50 (+1.56%)
LEGN : 39.75 (-0.97%)
CVRX : 14.77 (+9.25%)
PTGX : 41.65 (+2.46%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised...

CVRX : 14.77 (+9.25%)
Bronstein, Gewirtz & Grossman, LLC Notifies CVRx, Inc. (CVRX) Investors of Investigation

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of investors of CVRx, Inc. (“CVRx” or “the Company”) (NASDAQ: CVRX). CVRx investors are encouraged...

CVRX : 14.77 (+9.25%)

Business Summary

CVRx Inc. is a commercial-stage medical device company. It focused on developing, manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx Inc. is headquartered in Minneapolis, MN.

See More

Key Turning Points

3rd Resistance Point 16.67
2nd Resistance Point 15.74
1st Resistance Point 15.25
Last Price 14.77
1st Support Level 13.83
2nd Support Level 12.90
3rd Support Level 12.41

See More

52-Week High 33.13
Fibonacci 61.8% 22.92
Fibonacci 50% 19.77
Fibonacci 38.2% 16.61
Last Price 14.77
52-Week Low 6.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar